FDBK vs. INHC, COG, RENX, PXS, NSCI, OBI, GENI, ABDX, SNG, and BELL
Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), Cambridge Cognition (COG), Renalytix (RENX), Provexis (PXS), NetScientific (NSCI), Ondine Biomedical (OBI), GENinCode (GENI), Abingdon Health (ABDX), Synairgen (SNG), and Belluscura (BELL). These companies are all part of the "medical" sector.
Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote.
52.8% of Feedback shares are owned by institutional investors. Comparatively, 42.4% of Induction Healthcare Group shares are owned by institutional investors. 11.0% of Feedback shares are owned by company insiders. Comparatively, 46.7% of Induction Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Feedback has higher earnings, but lower revenue than Induction Healthcare Group. Feedback is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Induction Healthcare Group had 3 more articles in the media than Feedback. MarketBeat recorded 4 mentions for Induction Healthcare Group and 1 mentions for Feedback. Induction Healthcare Group's average media sentiment score of 0.35 beat Feedback's score of 0.34 indicating that Induction Healthcare Group is being referred to more favorably in the news media.
Feedback has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its share price is 141% less volatile than the S&P 500.
Feedback has a net margin of 0.00% compared to Induction Healthcare Group's net margin of -120.26%. Feedback's return on equity of -32.67% beat Induction Healthcare Group's return on equity.
Summary
Induction Healthcare Group beats Feedback on 8 of the 15 factors compared between the two stocks.
Get Feedback News Delivered to You Automatically
Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FDBK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Feedback Competitors List
Related Companies and Tools
